Page 8 - சொத்து கொள்முதல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com s offering. The Global Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2020 report provides comprehensive access to available records for over 1,100 asset purchase deals, including contract documents where available. The report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The focus of the report is on partnerships for business, product, technology and royalty assets where partners have entered an agreement to dispose of or acquire said assets. Companies may seek to dispose of an asset simply because it is surplus to requirements. Or it may seek to dispose of assets in order to raise funds to invest in others parts of its business. Or it may be due to a regulatory requirement to dispose of certain business or product assets as a result of a pending business merger in order to meet competition regulations.

Eli lillyKyowa hakkoLaura woodSecurities exchange commissionOffice hours callE st office hours callBiogen idecBiotime acquisition geron corporationValeant pharmaceuticalsAsset purchase partnering termsGlobal asset purchase dealsCurrent agreementsAsset purchase dealsTopics coveredAsset purchaseBiotime acquisition